Sort
27,075 grants matching “cholesterol”
Multiscale, Transport-Dependent NO Signaling: Cells to Vascular Networks
$665,060Dov Jaron · Drexel University · U01 · FY2015 · HL
Oral Infections and Vascular Disease Epidemiology Study (INVEST)
$665,052Moise Desvarieux · Columbia University Health Sciences · R01 · FY2016 · DE
CAREER: Investigating the Molecular Factors that Underlie Myelin-Associated Glycoprotein Binding
$664,948Nathan J Wittenberg · Lehigh University · · FY2021 · BIO
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
$664,926Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2023 · HL
Health and Economic Effects of Light Rail Lines: A Natural Experiment
$664,856Stephen Paul Fortmann · Kaiser Foundation Research Institute · R01 · FY2016 · DK
Dynamically Tailoring Interventions for Problem-Solving in Diabetes Self-Management Using Self-Monitoring Data - a Randomized Controlled Trial.
$664,466Olena Mamykina · Columbia University Health Sciences · R01 · FY2020 · DK
Assessing causality: Is post-traumatic stress disorder cardio-toxic?
$664,368Karestan C Koenen · Harvard School Of Public Health · R01 · FY2016 · MH
Dose-response to resistance exercise on cardiovascular health
$664,350Duck-Chul Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Deciphering Mechanisms for Triglyceride and Cholesterol Transport
$664,190Stephen G Young · University Of California Los Angeles · P01 · FY2019 · HL
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2019 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2020 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2018 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2021 · DK
Comprehensive Characterization of Glycosylation Alterations in Alzheimer's Disease
$664,010Angela M Zivkovic · University Of California At Davis · R01 · FY2020 · AG
Comprehensive Characterization of Glycosylation Alterations in Alzheimerâs Disease
$664,010Angela M Zivkovic · University Of California At Davis · R01 · FY2019 · AG
Comprehensive Characterization of Glycosylation Alterations in Alzheimer's Disease
$664,010Angela M Zivkovic · University Of California At Davis · R01 · FY2021 · AG
Targeting of proteins into peroxisomes
$664,000Suresh Subramani · University Of California, San Diego · R01 · FY2025 · DK
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins
$663,909Tomas G Neilan · Massachusetts General Hospital · R01 · FY2019 · HL
BRIGHTEN HEART: REDUCING DISPARITIES IN LATE LIFE DEPRESSION & METABOLIC SYNDROME
$663,778Steven K Rothschild · Rush University Medical Center · P50 · FY2013 · HL
EPIDEMIOLOGY OF AGE RELATED OCULAR DISEASE
$663,766University Of Wisconsin Madison · U10 · FY2001 · EY
Epigenetics of Weight Loss and Glycemic Improvement
$663,562Jingzhong Ding · Wake Forest University Health Sciences · R01 · FY2017 · DK
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
$663,529Scott Michael Damrauer · University Of Pennsylvania · R01 · FY2023 · HL
Community-based approach to Early Identification of transitions to Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) in African Americans
$663,484Voyko Kavcic · Wayne State University · R01 · FY2020 · AG
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS
$663,467Nathan Oliver Stitziel · Washington University · R01 · FY2017 · HL
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events
$663,375University Of Washington · U01 · FY2005 · HL